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Keio University Medical School, Tokyo, Japan Th e mushroom Poria cocos (Polyporaceae) is used in approximately 30% of all Kampo (traditional Japanese herbal medicine) formulas. It consists of several pharmacologically active ingredients, including the vitamin D precursor ergosterol and the triterpene pachymic acid.
In Kampo, P. cocos is known as bukuryo and is only used in combination with other herbs. To date, little research has been done on this mushroom in isolation. However, extracts have demonstrated the inhibition of tumor promotion, infl ammation, induction, and red cell lysis by reactive oxygen species. In clinical use, poria is part of the multi-herb formulas used for enhancing immunocompetence; in treating suidoku (traditional Kampo medicine diagnosis, which roughly translates into "water overload")and various women's health issues, and has many more indications. Currently, poria is part of a United States Food and Drug Administration (FDA)-approved trial of a non-estrogenic multi-herb formula for the management of menopausal hot fl ashes.
In Japan, 148 Kampo formulas are prescribed by physicians on a regular basis. Th ese are pharmaceutical grade, government-regulated prescription medicines that medical students are taught to prescribe and that are covered by the National Health Service. Some poria-containing formulas are more than 1800 years old. Signifi cant clinical experience and preclinical research exists on the dozens of Poria-containing formulas that are prescribed today.
Poria cocos, as a formula ingredient, is not from a fruiting body but is actually cut from the mycelial mass that grows in the ground under certain species of pine in Japan and China. Th e harvested mycelial mass is wet and soft; the form used in Kampo herbal medicines is dry and hard. Traditionally, poria was cut into small (<1 cm³) cubes and set in the sun to dry. Th is treatment, by necessity, would expose the large surface area of the mushroom mycelia to solar UV-B radiation, which in turn would transform the ergosterol to ergocalciferol-vitamin D₂.
One of Kampo's most famous practitioners, Keisetsu Otsuka, in 1965 published Kampo Shinryou San Ju Nen, which summarized 374 representative cases from his practice in the years 1931-1959. Th is presentation will share two translated case studies in which two Poria cocos-containing formulas (yokukan-san and hachi-miji-ou-gan) were prescribed with remarkable success. Th ese cases will be analyzed from the perspective of contemporary scientifi c and medical knowledge to argue that vitamin D from sundried poria was the active ingredient most responsible for the patients' recovery. Implications for both the interpretation of historical use and the generation of contemporary research will be discussed.
Th is presentation will argue that Poria cocos deserves greater attention as an agent for promoting human health. Certainly P. cocos, like other medicinal mushrooms, can be a signifi cant source of vitamin D. In addition, many mushroom triterpenes are also pharmacologically active, and P. cocos documented actions are not all attributable to vitamin D.
